{"id":12560,"date":"2024-09-29T20:41:23","date_gmt":"2024-09-30T00:41:23","guid":{"rendered":"https:\/\/economicherald.net\/?p=12560"},"modified":"2024-09-29T20:41:23","modified_gmt":"2024-09-30T00:41:23","slug":"long-shortz-with-pharmaust-sweet-incentives-for-sad-diseases-drug-development","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=12560","title":{"rendered":"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development"},"content":{"rendered":"<p class=\"p1\">Stockhead\u2019s Sarah Hughan sits down with <a href=\"https:\/\/stockhead.com.au\/company\/pharmaust-paa\/\">PharmAust (ASX:PAA)<\/a> managing director Dr Michael Thurn to get the short end of the long story on the company\u2019s latest news.<\/p>\n<p>The biotech has requested Orphan Medicinal Product Designation in the EU for its drug to treat amyotrophic lateral sclerosis, the most common form of motor neurone disease.<\/p>\n<p>It already received the same designation from the US Food and Drug Administration earlier this year.<\/p>\n<p class=\"p1\">Tune in to hear PharmAust\u2019s Dr Michael Thurn on the debilitating disease, the pathway to drug approval, and more.<\/p>\n<p>\u00a0<\/p>\n<p class=\"p3\">This video was developed in collaboration with PharmAust, a Stockhead advertiser at the time of publishing.<\/p>\n<p class=\"p3\">The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions. <\/p>\n<p>The post <a href=\"https:\/\/stockhead.com.au\/stockhead-tv\/long-shortz\/long-shortz-with-pharmaust-sweet-incentives-for-sad-diseases-drug-development\/\">Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development<\/a> appeared first on <a href=\"https:\/\/stockhead.com.au\/\">Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Stockhead\u2019s Sarah Hughan sits down with PharmAust (ASX:PAA) managing director Dr Michael Thurn to get the short end of the long story on the company\u2019s <a href=\"https:\/\/economicherald.net\/?p=12560\" class=\"read-more-link\">[more&#8230;]<\/a><\/p>\n","protected":false},"author":0,"featured_media":12561,"comment_status":"","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-12560","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=12560\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"Stockhead\u2019s Sarah Hughan sits down with PharmAust (ASX:PAA) managing director Dr Michael Thurn to get the short end of the long story on the company\u2019s [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=12560\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-30T00:41:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development\",\"datePublished\":\"2024-09-30T00:41:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/LONG-SHORTZ-6-2HA2Sy.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=12560\",\"name\":\"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/LONG-SHORTZ-6-2HA2Sy.jpeg\",\"datePublished\":\"2024-09-30T00:41:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=12560\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/LONG-SHORTZ-6-2HA2Sy.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/LONG-SHORTZ-6-2HA2Sy.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=12560#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=12560","og_locale":"en_US","og_type":"article","og_title":"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development - Economic Herald","og_description":"Stockhead\u2019s Sarah Hughan sits down with PharmAust (ASX:PAA) managing director Dr Michael Thurn to get the short end of the long story on the company\u2019s [more...]","og_url":"https:\/\/economicherald.net\/?p=12560","og_site_name":"Economic Herald","article_published_time":"2024-09-30T00:41:23+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=12560#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=12560"},"author":{"name":"","@id":""},"headline":"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development","datePublished":"2024-09-30T00:41:23+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=12560"},"wordCount":170,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=12560#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/09\/LONG-SHORTZ-6-2HA2Sy.jpeg","articleSection":["Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=12560","url":"https:\/\/economicherald.net\/?p=12560","name":"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=12560#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=12560#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/09\/LONG-SHORTZ-6-2HA2Sy.jpeg","datePublished":"2024-09-30T00:41:23+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=12560#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=12560"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=12560#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/09\/LONG-SHORTZ-6-2HA2Sy.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/09\/LONG-SHORTZ-6-2HA2Sy.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=12560#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"Long Shortz with PharmAust: Sweet incentives for sad disease\u2019s drug development"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/12560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12560"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/12560\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/12561"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}